ENOXA (enoxaparin sodium)
Product Description
Les Laboratoires Medis
-
Country/Region:Tunisia
-
On CPHI since:2018
Categories
Les Laboratoires Medis
-
Country/Region:Tunisia
-
On CPHI since:2018
More Products from Les Laboratoires Medis (2)
-
Product BORTESOMIB NEAPOLIS (bortezomib)
Bortezomib NEAPOLIS for Injection is an antineoplastic agent available for intravenous injection (IV) use only.
Each single dose vial contains 3.5 mg of Bortezomib as a sterile lyophilized powder -
Product EPOMAX 2000 (RECOMBINANT HUMAN ERYTHROPOEITIN ALPHA? 2000 UI / 1 ml)
After granting the Marketing Authorization of THE FIRST Human Recombinant alpha Erythropoietin (EPO), MédiS becomes the FIRST Tunisian pharmaceutical company to produce and market its biosimilar EPO commercially appointed as EPOMAX®.
Les Laboratoires Medis resources (1)
-
Brochure MediS Presentation : Company Profile
This presentation describes the history and the keys dates of MédiS Group